TopNews + Font Resize -

TN IDMA to conduct workshop in Pondicherry on technical, regulatory aspects of drug manufacturing on Dec 19
Our Bureau, Chennai | Wednesday, December 17, 2014, 08:00 Hrs  [IST]

With a view to update the current and emerging information on the technical aspects in the pharmaceutical industry with the pharma manufacturers in Pondicherry, the Indian Drugs Manufacturers Association Tamil Nadu board (TN IDMA) is conducting a scientific workshop in the Union territory on Friday, December 19.

The workshop will also educate them on how the legal and ethical issues must be considered and applied in the day-to-day work of pharma production.

Among the four sessions, the first two sessions will be on good manufacturing practices (GMP) and good laboratory practices (GLP)), mainly to share the latest developments and knowledge in the field.

According to sources from TN IDMA, this is the first time a workshop of this kind is held for the industry people in Pondicherry. The Pondicherry drugs manufacturers association (PDMA) is associating with TN IDMA, besides, all the 140 manufacturing units in the UT has separate individual membership with IDMA, said M Rajaratinam, chairman of TN IDMA.

Senior professionals from the departments of quality assurance (QA) and quality control (QC) of  leading manufacturing companies in Maharashtra, Gujarat, Andhra Pradesh and Tamil Nadu will lead the sessions.

“IDMA is conducting this kind of workshop in Pondicherry to help the manufacturers there to update the latest developments in the industry and in regulatory affairs. The industry should be  updated with the latest techniques of all the departments in the production lines. Though the union territory is small in area wise, there are 140 manufacturing units and all of them have GMP facilities and they are producing quality products. They are unable to come to Chennai every time to attend this kind of workshops, so we have decided to conduct one workshop there. We hope that the workshop will increase the performance outcomes, skills and knowledge required to develop the pharma production field”, said Rajaratinam who coordinates the programme.

Post Your Comment

 

Enquiry Form